Skip to main content

Prediction of Alzheimer’s Disease in Mild Cognitive Impairment Using Sulcal Morphology and Cortical Thickness

  • Conference paper
  • First Online:
World Congress on Medical Physics and Biomedical Engineering 2018

Part of the book series: IFMBE Proceedings ((IFMBE,volume 68/1))

Abstract

Mild cognitive impairment (MCI) is an intermediate condition between healthy ageing and dementia. The amnestic MCI is often a high risk factor for subsequent Alzheimer’s disease (AD) conversion. Some MCI patients never develop AD (MCI non-converters, or MCInc), but some do progress to AD (MCI converters, or MCIc). The purpose of this study was to predict future AD-conversion in patients with MCI using machine learning with sulcal morphology and cortical thickness measures as classification features. 32 sulci per subject were extracted from 1.5T T1-weighted ADNI database MRI scans of 90 MCIc and 104 MCInc subjects. We computed sulcal morphology features and cortical thickness measurements for support vector machine classification to identify structural patterns distinguishing future AD conversions. The linear kernel classifier trained with these features was able to predict 87.0% of MCI subjects as future converters, (89.7% sensitivity, 84.4% specificity, 0.94 AUC), using 10-fold cross-validation. These results using sulcal and cortical features are superior to the state-of-the-art methods. The most discriminating predictive features were observed in the temporal and frontal lobes in the left hemispheres, and in the entorhinal cortices, which is consistent with literature. However, we also observed structural changes in the cingulate and calcarine cortices, suggesting that the limbic and occipital lobe atrophy may be linked to AD conversion.

for the Alzheimer’s Disease Neuroimaging Initiative

Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Morris, J.C. and Cummings, J., 2005. Mild cognitive impairment (MCI) represents early-stage Alzheimer’s disease. Journal of Alzheimer’s Disease, 7(3), pp. 235–239.

    Google Scholar 

  2. Gauthier, S., Reisberg, B., Zaudig, M., Petersen, R.C., Ritchie, K., Broich, K., Belleville, S., Brodaty, H., Bennett, D., Chertkow, H. and Cummings, J.L., 2006. Mild cognitive impairment. The Lancet, 367(9518), pp. 1262–1270.

    Google Scholar 

  3. Chan, D., Fox, N.C., Scahill, R.I., Crum, W.R., Whitwell, J.L., Leschziner, G., Rossor, A.M., Stevens, J.M., Cipolotti, L. and Rossor, M.N., 2001. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer’s disease. Annals of neurology, 49(4), pp. 433–442.

    Google Scholar 

  4. Jack, C.R., Petersen, R.C., Xu, Y., O’Brien, P.C., Smith, G.E., Ivnik, R.J., Tangalos, E.G. and Kokmen, E., 1998. Rate of medial temporal lobe atrophy in typical aging and Alzheimer’s disease. Neurology, 51(4), pp. 993–999.

    Google Scholar 

  5. Cho, H., Jeon, S., Kang, S.J., Lee, J.M., Lee, J.H., Kim, G.H., Shin, J.S., Kim, C.H., Noh, Y., Im, K. and Kim, S.T., 2013. Longitudinal changes of cortical thickness in early-versus late-onset Alzheimer’s disease. Neurobiology of aging, 34(7), pp. 1921–e9.

    Google Scholar 

  6. Braak, H. and Braak, E., 1991. Neuropathological stageing of Alzheimer-related changes. Acta neuropathologica, 82(4), pp. 239–259.

    Google Scholar 

  7. Krumm, S., Kivisaari, S.L., Probst, A., Monsch, A.U., Reinhardt, J., Ulmer, S., Stippich, C., Kressig, R.W. and Taylor, K.I., 2016. Cortical thinning of parahippocampal subregions in very early Alzheimer’s disease. Neurobiology of aging, 38, pp. 188–196.

    Google Scholar 

  8. Cho, Y., Seong, J.K., Jeong, Y., Shin, S.Y. and Alzheimer’s Disease Neuroimaging Initiative, 2012. Individual subject classification for Alzheimer’s disease based on incremental learning using a spatial frequency representation of cortical thickness data. Neuroimage, 59(3), pp. 2217–2230.

    Google Scholar 

  9. Querbes, O., Aubry, F., Pariente, J., Lotterie, J.A., Démonet, J.F., Duret, V., Puel, M., Berry, I., Fort, J.C., Celsis, P. and Alzheimer’s Disease Neuroimaging Initiative, 2009. Early diagnosis of Alzheimer’s disease using cortical thickness: impact of cognitive reserve. Brain, 132(8), pp. 2036–2047.

    Google Scholar 

  10. Eskildsen, S.F., Fonov, V., Coupé, P., Østergaard, L.R. and Collins, D.L., 2011. Prediction of Alzheimer’s disease in subjects with mild cognitive impairment using structural patterns of cortical thinning. In 15th Nordic-Baltic Conference on Biomedical Engineering and Medical Physics (NBC 2011) (pp. 156–159). Springer, Berlin, Heidelberg.

    Google Scholar 

  11. Westman, E., Muehlboeck, J.S. and Simmons, A., 2012. Combining MRI and CSF measures for classification of Alzheimer’s disease and prediction of mild cognitive impairment conversion. Neuroimage, 62(1), pp. 229–238.

    Google Scholar 

  12. Eskildsen, S.F., Coupé, P., Fonov, V.S., Pruessner, J.C. and Collins, D.L., 2015. Structural imaging biomarkers of Alzheimer’s disease: predicting disease progression. Neurobiology of aging, 36, pp. S23–S31.

    Google Scholar 

  13. Misra, C., Fan, Y. and Davatzikos, C., 2009. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. Neuroimage, 44(4), pp. 1415–1422.

    Google Scholar 

  14. Im, K., Lee, J.M., Seo, S.W., Kim, S.H., Kim, S.I. and Na, D.L., 2008. Sulcal morphology changes and their relationship with cortical thickness and gyral white matter volume in mild cognitive impairment and Alzheimer’s disease. Neuroimage, 43(1), pp. 103–113.

    Google Scholar 

  15. Plocharski, M., Østergaard, L.R. and Alzheimer’s Disease Neuroimaging Initiative, 2016. Extraction of sulcal medial surface and classification of Alzheimer’s disease using sulcal features. Computer methods and programs in biomedicine, 133, pp. 35–44.

    Google Scholar 

  16. Hamelin, L., Bertoux, M., Bottlaender, M., Corne, H., Lagarde, J., Hahn, V., Mangin, J.F., Dubois, B., Chupin, M., De Souza, L.C. and Colliot, O., 2015. Sulcal morphology as a new imaging marker for the diagnosis of early onset Alzheimer’s disease. Neurobiology of aging, 36(11), pp. 2932–2939.

    Google Scholar 

  17. Garde, A., Voss, A., Caminal, P., Benito, S. and Giraldo, B.F., 2013. SVM-based feature selection to optimize sensitivity−specificity balance applied to weaning. Computers in biology and medicine, 43(5), pp. 533–540.

    Google Scholar 

  18. Cai, K., Xu, H., Guan, H., Zhu, W., Jiang, J., Cui, Y., Zhang, J., Liu, T. and Wen, W., 2017. Identification of early-stage Alzheimer’s disease using sulcal morphology and other common neuroimaging indices. PloS one, 12(1), p.e0170875.

    Google Scholar 

  19. Andersen, S.K., Jakobsen, C.E., Pedersen, C.H., Rasmussen, A.M., Plocharski, M. and Østergaard, L.R., 2015, June. Classification of Alzheimer’s disease from MRI using sulcal morphology. In Scandinavian Conference on Image Analysis (pp. 103–113). Springer, Cham.

    Google Scholar 

  20. Zheng, W., Yao, Z., Hu, B., Gao, X., Cai, H. and Moore, P., 2015. Novel cortical thickness pattern for accurate detection of Alzheimer’s disease. Journal of Alzheimer’s Disease, 48(4), pp. 995–1008.

    Google Scholar 

  21. Eskildsen, S.F., Coupé, P., García-Lorenzo, D., Fonov, V., Pruessner, J.C., Collins, D.L. and Alzheimer's Disease Neuroimaging Initiative, 2013. Prediction of Alzheimer’s disease in subjects with mild cognitive impairment from the ADNI cohort using patterns of cortical thinning. Neuroimage, 65, pp. 511–521.

    Google Scholar 

Download references

Acknowledgements

Support for this research was provided by The Lundbeck Foundation. Data collection and sharing for this project was funded by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education; the study is coordinated by the Alzheimer’s Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maciej Plocharski .

Editor information

Editors and Affiliations

Ethics declarations

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Plocharski, M., Østergaard, L.R. (2019). Prediction of Alzheimer’s Disease in Mild Cognitive Impairment Using Sulcal Morphology and Cortical Thickness. In: Lhotska, L., Sukupova, L., Lacković, I., Ibbott, G.S. (eds) World Congress on Medical Physics and Biomedical Engineering 2018. IFMBE Proceedings, vol 68/1. Springer, Singapore. https://doi.org/10.1007/978-981-10-9035-6_13

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-9035-6_13

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-9034-9

  • Online ISBN: 978-981-10-9035-6

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics